Publicly funded opioid abuse therapy costeffective in USA

Publicly funded opioid abuse therapy costeffective in USA PharmacoEconomics & Outcomes News 792, p25 - 2 Dec 2017 Publicly funded opioid abuse therapy cost effective in USA Publicly funded opioid abuse therapy (OAT) appears to be cost effective, according to findings of a US study published in Annals of Internal Medicine. A semi-Markov model was used to evaluate the cost effectiveness and budget impact of immediate access to opioid abuse therapy with methadone in a hypothetical population of patients 35 years of age with opioid abuse disorder (primarily due to heroin) presenting at publicly funded treatment centers in California, compared with the standard of care (short- term medically managed withdrawal), from a societal perspective over a lifetime time horizon. The model was populated with data from linked treatment and criminal justice administrative databases. Immediate access to opioid abuse therapy was estimated to gain 0.42 additional QALYs compared with the standard of care and to reduce total costs by $78 257 over a lifetime. Opioid abuse therapy was therefore dominant (more effective and less costly). It was estimated that treatment of all patients with opioid use disorder in California in 2014 with immediate opioid abuse therapy would achieve total lifetime savings $3.8 billion. Sensitivity analysis found that opioid abuse therapy was cost effective in 99.6% of simulations. "Our findings further underline the need for widespread and unencumbered access to evidence- based treatment of opioid use disorder to reduce the burden to society of the current prescription opioid and heroin use epidemic," the authors commented. * 2016 US dollars Krebs E, et al. Cost-Effectiveness of Publicly Funded Treatment of Opioid Use Disorder in California Annals of Internal Medicine : 21 Nov 2017. Available from: URL: 803284965 1173-5503/17/0792-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved PharmacoEconomics & Outcomes News 2 Dec 2017 No. 792 PharmacoEconomics & Outcomes News Springer Journals

Publicly funded opioid abuse therapy costeffective in USA

1 page

Loading next page...
1 Page
Springer International Publishing
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Medicine & Public Health; Pharmacoeconomics and Health Outcomes; Quality of Life Research; Health Economics; Public Health
Publisher site
See Article on Publisher Site

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.

DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches


Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.



billed annually
Start Free Trial

14-day Free Trial